Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Prashant C. Shah

Dr. Prashant C. Shah

Thoracic Surgeon, Assistant Professor

In the typically rigid and scientific world of surgery, Dr. Prashant Shah takes a special approach to patient care. He focuses equally on medical care and emotional support.

Get in touch
Jump to a Topic:

About Prashant C. Shah

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Research Excellence icon

    Excellence in Research

  • Minimally Invasive Surgery icon

    Minimally Invasive Surgery

  • VAT Surgery icon

    Video-Assisted Thoracoscopic Surgery

  • Board Certified icon

    Board Certified in Surgery

  • Board Certified icon

    Board Certified in Thoracic Surgery

Shah joined the Baylor Scott & White Health network in 2016, bringing his multidisciplinary approach to the treatment of malignant pleural mesothelioma to Scott & White Medical Center – Temple.

He emphasizes helping patients fully understand what they are facing, what their options are, and being alongside them every step of the way.

“It is an emotional, life-altering period, where they have to struggle with making drastic changes and rational decisions regarding options to advance their treatment,” he said. “My foremost goal is for the patients and their family members to understand the multiple options that are available, and to understand that they are not alone.”

With patients, he stresses the advantage of finding mesothelioma expertise like they have at the Baylor Scott & White Health network, which includes the Baylor University Medical Center in Dallas.

Shah also talks about hope, leaving behind the gloom-and-doom attitude that once was so prevalent when discussing mesothelioma, a cancer with no definitive cure.

“We’re not moving mountains, but we are making steady progress. There is reason for hope now with mesothelioma,” he told “There still is a long way to go, but we’ve come a long way, too. Attitudes [toward mesothelioma] are changing.”

Experience with Pleurectomy and Decortication

Shah’s clinical expertise is based around an innovative multimodal approach to complex thoracic cancers, including mesothelioma, lung cancer, thymic carcinoma, mediastinal tumors, esophageal cancer and chest wall masses.

He performs all surgical options for mesothelioma, including the lung-sparing pleurectomy and decortication (P/D) for patients who qualify based on a variety of factors.

P/D often is accompanied by photodynamic therapy and a heated povidone-iodine wash to help eliminate any microscopic cancer cells left behind.

Shah also has earned a reputation for his skill in cutting- edge, minimally invasive surgical procedures that help patients shorten their post-surgery recovery.

Doctor talking to patients

Talk to a Doctor About Your Diagnosis

We can help you or a loved one get in contact with Dr. Shah and find the treatment that's best for you.

Get Started Today

Previous Stops Include Fox Chase and Brigham & Women’s

Shah came to Baylor Scott & White Health after five years as a thoracic surgeon at the prestigious Fox Chase Cancer Center in Philadelphia. He spent the two previous years as a Harvard clinical instructor at Brigham & Women’s Hospital in Boston.

He often shares medical experiences from his previous work, including his fellowships and residencies.

During extensive post-graduate training at institutions such as the State University of New York and Harvard University, Shah fostered a wide range of specialized medical interests. After his general surgery residency, he completed intensive studies for cardiothoracic surgery, thoracic oncology and minimally invasive thoracic surgery.

The rigorous training in all of these fields gave Shah the knowledge necessary to treat patients with complex chest cancers.

At Fox Chase Cancer Center, Shah performed minimally invasive and video-guided operations to provide his patients with the lowest risk of complications and the speediest post-operative recovery times possible.

At the sixth-annual Advances in Thoracic Oncology Conference, he spoke on a variety of topics, including the mesothelioma staging system, adjuvant therapies and different surgical strategies.

His team at Scott & White includes medical oncologists, pulmonologists and radiation oncologists. It also includes Dr. David Mason, chief of thoracic surgery and lung transplantation.

Shah’s earlier clinical research dealt with airway obstruction, intrapleural pressure, open heart surgery and other topics in cardiovascular and thoracic surgery.

He was the lead presenter for an International Academy of Cardiology presentation discussing how secondary risk factors associate with cardiac surgery.

See More Top Mesothelioma Doctors

Disclaimer: Dr. Prashant C. Shah has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Baylor Scott & White Health. (n.d.). Prashant Chandrakant Shah, M.D.
    Retrieved from:
  2. Fox Chase Cancer Center. (2010, October 15). Prashant C. Shah, MD, Joins Fox Chase’s Department of Surgical Oncology. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 9, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now